Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Recent research reveals Alzheimer's may progress faster in women due to alpha-synuclein, opening new research paths and ...

Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...

Last year, the National Institute of Health and Care Excellence (Nice) rejected the NHS rollout of the first two drugs – lecanemab and donanemab – that were found to halt the progression of disease.

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

For decades, Alzheimer’s disease has been framed as a one‑way slide, a slow erasure of memory that medicine could at best delay. That narrative is starting to crack. A wave of lab discoveries, smarter ...

Alzheimer’s Research UK are calling on the government to work with industry, researchers and the NHS to set up pilot trials.

The brains of “superagers” with exceptional memory skills have superior abilities to grow new neurons, a groundbreaking study ...